Back
Mersana Therapeutics Stock Price Chart

7 Stocks to Consider Immediately (must-see chart)
See the green days for 7 major stocks right here, free of charge
Sell
12
MRSN
Mersana Therapeutics
Last Price:
$0.31
Seasonality Move:
-25.5%
7 Day Trial
ALL ACCESS PASS
$
7

ALERT: Q3 Could Be a Pivotal Quarter for Nasdaq Stocks
Click Here to Download Your FREE Stock Report Now-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MRSN is experiencing slight selling pressure.
Mersana Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.31 | Sell |
20-day SMA: | 0.35 | Sell |
50-day SMA: | 0.36 | Sell |
200-day SMA: | 1.08 | Sell |
8-day EMA: | 0.3 | Sell |
20-day EMA: | 0.33 | Sell |
50-day EMA: | 0.37 | Sell |
200-day EMA: | 0.97 | Sell |
Mersana Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 38.07 | Sell |
Chaikin Money Flow: | 334368 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.31 - 0.39) | Sell |
Bollinger Bands (100): | (0.31 - 0.51) | Sell |
Mersana Therapeutics Technical Analysis
Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Mersana Therapeutics Stock
Is Mersana Therapeutics Stock a Buy?
-
Mersana Therapeutics share price is 0.29 while MRSN 8-day simple moving average is 0.31, which is a Sell signal.
-
The stock price of MRSN is 0.29 while Mersana Therapeutics 20-day SMA is 0.35, which makes it a Sell.
-
Mersana Therapeutics 50-day simple moving average is 0.36 while MRSN share price is 0.29, making it a Sell technically.
-
MRSN stock price is 0.29 and Mersana Therapeutics 200-day simple moving average is 1.08, creating a Sell signal.
MRSN Technical Analysis vs Fundamental Analysis
Sell
12
Mersana Therapeutics (MRSN)
is a Sell
Is Mersana Therapeutics a Buy or a Sell?
-
Mersana Therapeutics stock is rated a SellThe current Mersana Therapeutics [MRSN] share price is $0.29. The Score for MRSN is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.
Mersana Therapeutics Stock Info
Market Cap:
36.1M
Price in USD:
0.29
Share Volume:
1.9M
Mersana Therapeutics 52-Week Range
52-Week High:
2.83
52-Week Low:
0.26
Sell
12
Mersana Therapeutics (MRSN)
is a Sell
Mersana Therapeutics Share Price Forecast
-
What is the Mersana Therapeutics stock price today?The Mersana Therapeutics stock price is 0.29 USD today.
-
Will MRSN stock go up or go down?Mersana Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Mersana Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Mersana Therapeutics is overvalued.
Is Mersana Therapeutics Stock a Buy?
-
Mersana Therapeutics share price is 0.29 while MRSN 8-day exponential moving average is 0.30, which is a Sell signal.
-
The stock price of MRSN is 0.29 while Mersana Therapeutics 20-day EMA is 0.33, which makes it a Sell.
-
Mersana Therapeutics 50-day exponential moving average is 0.37 while MRSN share price is 0.29, making it a Sell technically.
-
MRSN stock price is 0.29 and Mersana Therapeutics 200-day simple moving average is 0.97, creating a Sell signal.
Fundamental Analysis of Mersana Therapeutics
Is Mersana Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.06 per share, an increase this year of $0.01 per share, and a decrease next year of $0.05 per share.
Technical Analysis of Mersana Therapeutics
Should I short Mersana Therapeutics stock?
-
MRSN Moving Average Covergence Divergence (MACD) indicator is -0.02, suggesting Mersana Therapeutics is a Sell
-
Mersana Therapeutics Relative Strength Index (RSI) is 38.07, which suggest Mersana Therapeutics is oversold
-
The Bollinger Bands (25) for Mersana Therapeutics is (0.31 - 0.39), which suggest Mersana Therapeutics is a Sell
-
The Bollinger Bands (100) for Mersana Therapeutics is (0.31 - 0.51), which suggest Mersana Therapeutics is a Sell
* Mersana Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.